Shares of Baxter International Inc. BAX slid 4.02% to $34.41 Wednesday, on what proved to be an all-around mixed trading ...

Baxter’s stock price fell to $36.42. Shareholders have lost 7.3% of their capital, which is disappointing considering the S&P ...

Investors in Baxter International Inc (Symbol: BAX) saw new options become available today, for the June 2026 expiration. One of the key data points that goes into the price an option buyer is ...

Barclays analyst Matt Miksic maintained a Buy rating on Baxter International (BAX – Research Report) on March 7 and set a price target of ...

Baxter International Inc. closed 20.10% short of its 52-week high of $44.01, which the company reached on March 8th.

Baxter International Inc. BAX recently introduced Voalte Linq , a lightweight, wearable badge powered by Scotty assistant, a voice-activated technology, at the 2025 HIMSS Global Healthcare Conference.

Barclays raised the firm’s price target on Baxter (BAX) to $41 from $39 and keeps an Overweight rating on the shares. The firm updated its ...

Clinical teams working in hospitals are constantly on the move, keeping up with urgent demands in a fast-paced environment. | ...

Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...